Financial
Latest full-year results from official filings.
FY2025 revenue $4.34bn (-0.7%); operating margin 18.6%; net income $850.0m.
Cash $1.63bn; debt $1.99bn.
- Official results release · Illumina · 28 Dec 2025
Illumina: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Feb 2025: China's commerce ministry added Illumina to its Unreliable Entity List; Illumina said it was in talks with the authorities. Jan 2026: Fierce reported Illumina was still working through its China export troubles.
- Illumina is on China's Unreliable Entity List and has lobbied the U.S. Congress on the Biosecurity Act · Yicai Global · 4 Feb 2025
- JPM26: Illumina working China path through its export troubles · Fierce Biotech · 1 Jan 2026
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
Jul 2025: Illumina agreed to pay $9.8m to settle a US False Claims Act whistleblower case alleging it sold genomic sequencing systems to federal agencies without adequate product cybersecurity (2016-2023); Illumina denied the allegations and liability. NHS DSPT status not yet checked.
- DOJ settles cyber qui tam action against Illumina for allegedly unsecured genomic sequencing products · Alston & Bird Privacy Blog · 31 Jul 2025
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
No product recalls, FDA/MHRA safety notices or warning letters involving Illumina found in HSH's search of the last 24 months.
Contract performance
Contract delivery, go-lives, terminations and disputes.
Jun 2025: Genomics England extended Illumina's 2019 whole genome sequencing contract for the NHS Genomic Medicine Service to Mar 2027 (with a buyer break option after Jul 2026), adding £4.67m to cover extra lab and staff costs.
- Whole Genome Sequencing Services contract modification notice · Find a Tender (UK Government) · 13 Jun 2025